Literature DB >> 19261319

Vaccination reduces the viral load and the risk of transmission of Jembrana disease virus in Bali cattle.

William G F Ditcham1, Joshua R Lewis, Robert J Dobson, Nining Hartaningsih, Graham E Wilcox, Moira Desport.   

Abstract

The efficacy of a tissue-derived vaccine, which is currently used in Indonesia to control the spread of Jembrana disease in Bali cattle, was determined by quantifying the viral load in plasma following experimental infection with Jembrana disease virus. Virus transmission is most likely to occur during the acute phase of infection when viral titers are greater than 10(6) genomes/ml. Vaccinated cattle were found to have a 96% reduction in viral load above this threshold compared to control cattle. This would reduce the chance of virus transmission as the number of days above the threshold in the vaccinated cattle was reduced by 33%. Viral loads at the onset and resolution of fever were significantly lower in the vaccinated cattle and immune function was maintained with the development of antibody responses to Env proteins within 10-24 days post challenge. There was, however, no significant reduction in the duration of the febrile period in vaccinated animals. The duration and severity of clinical parameters were found to be variable within each group of cattle but the quantification of viral load revealed the benefits of vaccinating to reduce the risk of virus transmission as well as to ameliorate disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19261319     DOI: 10.1016/j.virol.2009.02.008

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  4 in total

Review 1.  Prospects in Innate Immune Responses as Potential Control Strategies against Non-Primate Lentiviruses.

Authors:  Lorena de Pablo-Maiso; Ana Doménech; Irache Echeverría; Carmen Gómez-Arrebola; Damián de Andrés; Sergio Rosati; Esperanza Gómez-Lucia; Ramsés Reina
Journal:  Viruses       Date:  2018-08-17       Impact factor: 5.048

2.  In Vitro Evaluation of Chitosan-DNA Plasmid Complex Encoding Jembrana Disease Virus Env-TM Protein as a Vaccine Candidate.

Authors:  Januar Ishak; Lalu Unsunnidhal; Ronny Martien; Asmarani Kusumawati
Journal:  J Vet Res       Date:  2019-03-22       Impact factor: 1.744

3.  Anti-SU Antibody Responses in Client-Owned Cats Following Vaccination against Feline Leukaemia Virus with Two Inactivated Whole-Virus Vaccines (Fel-O-Vax® Lv-K and Fel-O-Vax® 5).

Authors:  Mark Westman; Jacqueline Norris; Richard Malik; Regina Hofmann-Lehmann; Yasmin A Parr; Emma Armstrong; Mike McDonald; Evelyn Hall; Paul Sheehy; Margaret J Hosie
Journal:  Viruses       Date:  2021-02-03       Impact factor: 5.048

4.  Comparative functional analysis of Jembrana disease virus Tat protein on lentivirus long terminal repeat promoters: evidence for flexibility at its N-terminus.

Authors:  Yang Su; Gang Deng; Yuanming Gai; Yue Li; Yang Gao; Jiansen Du; Yunqi Geng; Qimin Chen; Wentao Qiao
Journal:  Virol J       Date:  2009-10-28       Impact factor: 4.099

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.